Relationships between human intestinal absorption and polar interactions drug/phospholipids estimated by IAM-HPLC

International Journal of Pharmaceutics

Volumn 489, Issue 1-2, 2015, Pages 186-194

  Grumetto, Lucia ^a   Russo, Giacomo ^a   Barbato, Francesco ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

IAM HPLC; Intestinal absorption; Lipophilicity; Membrane; Oral bioavailability; Phospholipids

Indexed keywords

AMPHOLYTE; CARBAMAZEPINE; CEFALEXIN; CIMETIDINE; DESIPRAMINE; FLUINDOSTATIN; HYDROCHLOROTHIAZIDE; ISOTRETINOIN; KETOPROFEN; NAPROXEN; OCTANOL; PHOSPHOLIPID; PIROXICAM; PROPRANOLOL; RANITIDINE; TERBUTALINE; VERAPAMIL; ARTIFICIAL MEMBRANE; DRUG;

ACTIVE TRANSPORT; ARTICLE; BINDING AFFINITY; BLOOD BRAIN BARRIER; DRUG INTERACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMOBILIZED ARTIFICIAL MEMBRANE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPOPHILICITY; PH; PHOSPHOLIPID BILAYER; PRIORITY JOURNAL; SMALL INTESTINE ABSORPTION; STATIC ELECTRICITY; STOMACH PH; ARTIFICIAL MEMBRANE; CHEMISTRY; DEVICES; HUMAN; INTESTINE ABSORPTION; PROCEDURES;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG INTERACTIONS; HUMANS; INTESTINAL ABSORPTION; MEMBRANES, ARTIFICIAL; PHARMACEUTICAL PREPARATIONS; PHOSPHOLIPIDS;

EID: 84928966474     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2015.04.062     Document Type: Article

References (42)

1. M. Amato, F. Barbato, P. Morrica, F. Quaglia, and M.I. La Rotonda Interactions between amines and phospholipids: a chromatographic study on immobilized artificial membrane (IAM) stationary phase at various pH values Helv. Chim. Acta 83 2000 2836 2847
2. A. Avdeef Absorption and Drug Development: Solubility, Permeability, and Charge State second ed. 2012 John Wiley & Sons, Inc. N.J 310 318
3. F. Barbato, G. Caliendo, M.I. La Rotonda, P. Morrica, C. Silipo, and A. Vittoria Relationships between octanol-water partition data, chromatographic indices and their dependence on pH in a set of beta-adrenoceptor blocking agents Il Farmaco 45 6 1990 647 663
4. F. Barbato, M.I. La Rotonda, and F. Quaglia Chromatographic indices determined on an immobilized artificial membrane (IAM) column as descriptors of lipophilic and polar interactions of 4-phenyldihydropyridine calcium-channel blockers with biomembranes Eur. J. Med. Chem 31 1996 311 318
5. F. Barbato, M.I. La Rotonda, and F. Quaglia Interactions of nonsteroidal antiinflammatory drugs with phospholipids: comparison between octanol/buffer coefficients and chromatographic indexes on immobilized artificial membranes J. Pharm. Sci. 86 1997 225 229
6. F. Barbato, M.I. La Rotonda, and F. Quaglia Chromatographic indexes on immobilized artificial membranes for local anesthetics: relationships with activity data on closed sodium channels Pharm. Res. 14 1997 1699 1705
7. F. Barbato, B. Cappello, A. Miro, M.I. La Rotonda, and F. Quaglia Chromatographic indexes on immobilized artificial membranes for the prediction of transdermal transport of drugs Il Farmaco 53 1998 655 661
8. F. Barbato, G. di Martino, L. Grumetto, and M.I. La Rotonda Prediction of drug-membrane interactions by IAM-HPLC: effects of different phospholipid stationary phases on the partition of bases Eur. J. Pharm. Sci. 22 2004 261 269
9. F. Barbato, G. di Martino, L. Grumetto, and M.I. La Rotonda Can protonated beta-blockers interact with biomembranes stronger than neutral isolipophilic compounds? A chromatographic study on three different phospholipid stationary phases (IAM-HPLC) Eur. J. Pharm. Sci. 25 2005 379 386
10. F. Barbato The use of immobilized artificial membrane (IAM) chromatography for determination of lipophilicity Curr. Comput. Aided Drug Des. 02 4 2006 341 352
11. F. Barbato, V. Cirocco, L. Grumetto, and M.I. La Rotonda Comparison between immobilized artificial membrane (IAM) HPLC data and lipophilicity in n-octanol for quinolone antibacterial agents Eur. J. Pharm. Sci. 31 2007 288 297
12. E. Bernhard, and F. Zimmermann Contribution to the understanding of oxicam ionization constants Arzneim. Forsch. 34 6 1984 647 648
13. U. Bickel How to measure drug transport across the blood-brain barrier NeuroRx 2 1 2005 15 26
14. T. Braumann, G. Weber, and L.H. Gromme Quantitative structure-activity relationships for herbicides. Reversed phase liquid chromatographic retention parameters, log kw versus liquid-liquid partition coefficients as a model of the hydrophobicity of phenylureas, S-triazines and phenoxycarbonic acid derivatives J. Chromatogr. A 261 1983 329 343
15. +/peptide symporter (PEPT1), the uptake into Caco-2cell monolayers and the transepithelial flux Pharm. Res. 16 1 1999 55 61
16. J. Comer, and K. Tam Lipophilicity profiles: theory and measurement B. Testa, H. van de Waterbeemd, G. Folkers, R.H. Guy, Pharmacokinetic Optimization in Drug Research 2001 Wiley-VHCA Zurich 275 304
17. A. Ducarme, M. Neuwels, S. Goldstein, and R. Massingham IAM retention and blood brain barrier penetration Eur. J. Med. Chem. 33 1998 215 223
18. L. Grumetto, C. Carpentiero, and F. Barbato Lipophilic and electrostatic forces encoded in IAM-HPLC indexes of basic drugs: their role in membrane partition and their relationships with BBB passage data Eur. J. Pharm. Sci. 45 2012 685 692
19. L. Grumetto, C. Carpentiero, P. Di Vaio, F. Frecentese, and F. Barbato Lipophilic and polar interaction forces between acidic drugs and membrane phospholipids encoded in IAM-HPLC indexes: their role in membrane partition and relationships with BBB permeation data J. Pharm. Biomed. Anal. 75 2013 165 172
20. L. Grumetto, G. Russo, and F. Barbato Indexes of polar interactions between ionizable drugs and membrane phospholipids measured by IAM-HPLC: their relationships with data of blood-brain barrier passage Eur. J. Pharm. Sci. 65 2014 139 146
21. A.A. Gurtovenko, and I. Vattulainen Molecular mechanism for lipid flip-flops J. Phys. Chem. B 111 2007 13554 13559
22. E. Kepczyńska, J. Bojarski, P. Haber, and R. Kaliszan Retention of barbituric acid derivatives on immobilized artificial membrane stationary phase and its correlation with biological activity Biomed. Chromatogr. 14 4 2000 256 260
23. S. Khan, A. Guha, P.G. Yeole, and P. Katariya Strong cation exchange resin for improving physicochemical properties and sustaining release of ranitidine hydrochloride Indian J. Pharm. Sci. 69 5 2007 626 632
24. S.D. Krämer, D. Lombardi, A. Primorac, A.V. Thomae, and H. Wunderli-Allenspach Lipid-bilayer permeation of drug-like compounds Chem. Biodivers. 6 2009 1900 1916
25. M.I. La Rotonda, G. Amato, F. Barbato, C. Silipo, and A. Vittoria Relationships between octanol-water partition data, chromatographic indices and their dependence on pH in a set of nonsteroidal anti-inflammatory drugs Quant. Struct.-Act. Relat. 2 1983 168 173
26. V. Law, C. Knox, Y. Djoumbou, T. Jewison, A.C. Guo, Y. Liu, A. Maciejewski, D. Arndt, M. Wilson, V. Neveu, A. Tang, G. Gabriel, C. Ly, S. Adamjee, Z.T. Dame, B. Han, Y. Zhou, and D.S. Wishart DrugBank 4.0: shedding new light on drug metabolism Nucl. Acids Res. 42 1 2014 D1091 D1097
27. H. Lennernäs Human jejunal effective permeability and its correlation with preclinical drug absorption models J. Pharm. Pharmacol. 49 1997 627 638
28. H. Lennernäs Human in vivo regional intestinal permeability: importance for pharmaceutical drug development Mol. Pharm. 11 2014 12 23
29. A.J. Leo, C. Hansch, and D. Elkins Partition coefficients and their use Chem. Rev. 71 1971 525 616
30. X. Liu, B. Testa, and A. Fahr Lipophilicity and its relationship with passive drug permeation Pharm. Res. 28 2011 962 977
31. F. Lombardo, M.Y. Shalaeva, K.A. Tupper, F. Gao, and M.H. Abraham ElogPoct: a tool for lipophilicity determination in drug discovery J. Med. Chem. 43 2000 2922 2928
32. A. Pagliara, P.A. Carrupt, G. Caron, P. Gaillard, and B. Testa Lipophilicity profiles of ampholytes Chem. Rev. 97 1997 3385 3400
33. L. Panigrahi, S. Pattnaik, and S.K. Ghosal The effect of pH and organic ester penetration enhancers on skin permeation kinetics of terbutaline sulfate from pseudolatex-type transdermal delivery systems through mouse and human cadaver skins AAPS PharmSciTech 6 2 2005 E167 E173
34. F. Péhourcq, M. Matoga, and B. Bannwarth Diffusion of arylpropionate non-steroidal anti-inflammatory drugs into the cerebrospinal fluid: a quantitative structure-activity relationship approach Fundam. Clin. Pharmacol. 18 1 2004 65 70
35. A. Reichel, and D.J. Begley Potential of immobilized artificial membranes for predicting drug penetration across the blood-brain barrier Pharm. Res. 15 8 1998 1270 1274
36. T. Salminen, A. Pulli, and J. Taskinen Relationship between immobilised artificial membrane chromatographic retention and the brain penetration of structurally diverse drugs J. Pharm. Biomed. Anal. 15 4 1997 469 477
37. A. Taillardat-Bertschinger, F. Barbato, M.T. Quercia, P.A. Carrupt, M. Reist, M.I. La Rotonda, and B. Testa Structural properties governing retention mechanisms on immobilized artificial membrane (IAM) HPLC columns Helv. Chim. Acta 85 2002 519 532
38. A. Taillardat-Bertschinger, P.A. Carrupt, F. Barbato, and B. Testa Immobilized artificial membrane HPLC in drug research J. Med. Chem. 46 2003 655 665
39. R.S. Tsai, P.-A. Carrupt, N. El Tayar, Y. Giroud, P. Andrade, B. Testa, F. Brée, and J.-P. Tillement Physicochemical and structural properties of non-steroidal anti-inflammatory oxicams Helv. Chim. Acta 76 1993 842 854
40. H. Van de Waterbeemd, and B. Testa Drug Bioavailability: Estimation of Solubility, Permeability, Absorption and Bioavailability second ed. 2008 John Wiley & Sons, Inc. N.J 185 219
41. D. Vrakas, C. Giaginis, and A. Tsantili-Kakoulidou Electrostatic interactions and ionization effect in immobilized artificial membrane retention. A comparative study with octanol-water partitioning J. Chromatogr. A 1187 2008 67 78
42. S. Winiwarter, N.M. Bonham, F. Ax, A. Hallberg, H. Lennernäs, and A. Karlén Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach J. Med. Chem. 41 1998 4939 4949